Fractyl Health to Report Second Quarter 2026 Financial Results and Provide Business Updates on August 10, 2026
Fractyl Health, a clinical-stage metabolic therapeutics company focusing on obesity and type 2 diabetes treatments, announced it will report its second quarter 2026 financial results and provide business updates on August 10, 2026. The company is developing two key therapeutic candidates: Revita, a procedural therapy for weight maintenance after GL…